Is DR Horton Stock a Good Investment?

DR Horton Investment Advice

  DHI
To provide specific investment advice or recommendations on DR Horton stock, we recommend investors consider the following general factors when evaluating DR Horton. This will help you to make an informed decision on whether to include DR Horton in one of your diversified portfolios:
  • Examine DR Horton's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research DR Horton's leadership team and their track record. Good management can help DR Horton navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Household Durables space and any emerging trends that could impact DR Horton's business and its evolving consumer preferences.
  • Compare DR Horton's performance and market position to its competitors. Analyze how DR Horton is positioned in terms of product offerings, innovation, and market share.
  • Check if DR Horton pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about DR Horton's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in DR Horton stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if DR Horton is a good investment.
 
Sell
 
Buy
Hold
Macroaxis provides trade advice on DR Horton to complement and cross-verify current analyst consensus on DR Horton. Our advice engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure DR Horton is not overpriced, please confirm all DR Horton fundamentals, including its price to earning, net income, and the relationship between the shares owned by insiders and revenue . Given that DR Horton has a price to earning of 5.10 X, we urge you to verify DR Horton market performance and probability of bankruptcy to ensure the company can sustain itself this quarter and beyond given your latest risk tolerance and investing horizon.

Market Performance

Very WeakDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine DR Horton Stock

Researching DR Horton's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 83.0% of the company shares are held by institutions such as insurance companies. The book value of DR Horton was currently reported as 78.12. The company has Price/Earnings To Growth (PEG) ratio of 0.62. DR Horton recorded earning per share (EPS) of 14.34. The entity last dividend was issued on the 12th of November 2024. The firm had 4:3 split on the 17th of March 2005.
To determine if DR Horton is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding DR Horton's research are outlined below:
DR Horton generated a negative expected return over the last 90 days
Over 83.0% of the company shares are held by institutions such as insurance companies
On 19th of November 2024 DR Horton paid $ 0.4 per share dividend to its current shareholders
Latest headline from insidermonkey.com: Heres Why D.R. Horton Rose In Q3

DR Horton Quarterly Cost Of Revenue

7.45 Billion

DR Horton uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in DR Horton. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to DR Horton's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
18th of April 2024
Upcoming Quarterly Report
View
18th of July 2024
Next Financial Report
View
31st of March 2024
Next Fiscal Quarter End
View
5th of November 2024
Next Fiscal Year End
View
31st of December 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View
Earnings surprises can significantly impact DR Horton's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises DR Horton's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2010-11-12
2010-09-30-0.04-0.030.0125 
1998-04-21
1998-03-310.080.090.0112 
1998-01-20
1997-12-310.070.080.0114 
1999-01-19
1998-12-310.120.140.0216 
1998-07-21
1998-06-300.120.140.0216 
2012-07-27
2012-06-300.20.230.0315 
2011-11-11
2011-09-300.140.11-0.0321 
2011-01-27
2010-12-31-0.03-0.06-0.03100 

Know DR Horton's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as DR Horton is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DR Horton backward and forwards among themselves. DR Horton's institutional investor refers to the entity that pools money to purchase DR Horton's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Parnassus Investments Llc2024-09-30
4.3 M
Norges Bank2024-06-30
3.8 M
Greenhaven Associates Inc2024-09-30
3.7 M
Dimensional Fund Advisors, Inc.2024-09-30
3.4 M
Northern Trust Corp2024-09-30
2.9 M
Legal & General Group Plc2024-06-30
2.6 M
Smead Capital Management Inc2024-09-30
2.5 M
Arrowstreet Capital Limited Partnership2024-06-30
2.5 M
Amvescap Plc.2024-06-30
2.5 M
Vanguard Group Inc2024-09-30
34.4 M
Blackrock Inc2024-06-30
34.1 M
Note, although DR Horton's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

DR Horton's market capitalization trends

The company currently falls under 'Large-Cap' category with a total capitalization of 54.18 B.

Market Cap

653.96 Million

DR Horton's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets 0.13  0.10 
Return On Capital Employed 0.19  0.52 
Return On Assets 0.13  0.10 
Return On Equity 0.19  0.35 
The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.17 %, which entails that for every 100 dollars of revenue, it generated $0.17 of operating income.
Determining DR Horton's profitability involves analyzing its financial statements and using various financial metrics to determine if DR Horton is a good buy. For example, gross profit margin measures DR Horton's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of DR Horton's profitability and make more informed investment decisions.

Evaluate DR Horton's management efficiency

DR Horton has Return on Asset of 0.1113 % which means that on every $100 spent on assets, it made $0.1113 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1963 %, implying that it generated $0.1963 on every 100 dollars invested. DR Horton's management efficiency ratios could be used to measure how well DR Horton manages its routine affairs as well as how well it operates its assets and liabilities. As of now, DR Horton's Return On Capital Employed is increasing as compared to previous years. The DR Horton's current Return On Equity is estimated to increase to 0.35, while Return On Tangible Assets are projected to decrease to 0.1. As of now, DR Horton's Total Current Assets are increasing as compared to previous years. The DR Horton's current Other Assets is estimated to increase to about 6.3 B, while Non Currrent Assets Other are forecasted to increase to (159.1 M).
Last ReportedProjected for Next Year
Book Value Per Share 78.37  0.03 
Tangible Book Value Per Share 77.88  0.03 
Enterprise Value Over EBITDA 10.09  54.10 
Price Book Value Ratio 2.48  46.36 
Enterprise Value Multiple 10.09  54.10 
Price Fair Value 2.48  46.36 
Enterprise Value706 M670.7 M
Examining the leadership quality of DR Horton offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Dividend Yield
0.0095
Forward Dividend Yield
0.0095
Forward Dividend Rate
1.6
Beta
1.744

Basic technical analysis of DHI Stock

As of the 27th of November, DR Horton owns the Market Risk Adjusted Performance of (0.54), information ratio of (0.15), and Standard Deviation of 1.9. DR Horton technical analysis allows you to utilize past data patterns in order to determine a pattern that computes the direction of the firm's future prices.

DR Horton's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DR Horton insiders, such as employees or executives, is commonly permitted as long as it does not rely on DR Horton's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DR Horton insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

DR Horton's Outstanding Corporate Bonds

DR Horton issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DR Horton uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DHI bonds can be classified according to their maturity, which is the date when DR Horton has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand DR Horton's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing DR Horton's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider DR Horton's intraday indicators

DR Horton intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of DR Horton stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

DR Horton Corporate Filings

F4
21st of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
10K
19th of November 2024
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
30th of October 2024
Other Reports
ViewVerify
8K
29th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
DR Horton time-series forecasting models is one of many DR Horton's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary DR Horton's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

DHI Stock media impact

Far too much social signal, news, headlines, and media speculation about DR Horton that are available to investors today. That information is available publicly through DHI media outlets and privately through word of mouth or via DHI internal channels. However, regardless of the origin, that massive amount of DHI data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of DR Horton news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of DR Horton relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to DR Horton's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive DR Horton alpha.

DR Horton Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards DR Horton can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

DR Horton Historical Investor Sentiment

Investor biases related to DR Horton's public news can be used to forecast risks associated with an investment in DHI. The trend in average sentiment can be used to explain how an investor holding DHI can time the market purely based on public headlines and social activities around DR Horton. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
DR Horton's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for DR Horton and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average DR Horton news discussions. The higher the estimate score, the more favorable the investor's outlook on DR Horton.

DR Horton Corporate Directors

Michael BuchananIndependent DirectorProfile
Michael HewattIndependent DirectorProfile
Barbara AllenIndependent DirectorProfile
Bradley AndersonIndependent DirectorProfile
When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.12)
Dividend Share
1.2
Earnings Share
14.34
Revenue Per Share
111.689
Quarterly Revenue Growth
(0.05)
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between DR Horton's value and its price, as these two are different measures arrived at by various means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.